Anti-BRG1 antibody [EPNCIR111B]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
Rabbit Recombinant Monoclonal BRG1 antibody. Suitable for WB and reacts with Rat, Human samples. Cited in 2 publications.
View Alternative Names
Baf190a, Brg1, Snf2b, Snf2l4, Smarca4, Transcription activator BRG1, ATP-dependent helicase SMARCA4, BRG1-associated factor 190A, Protein brahma homolog 1, SNF2-beta, SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4, BAF190A
- WB
Unknown
Western blot - Anti-BRG1 antibody [EPNCIR111B] (AB133257)
All lanes:
Western blot - Anti-BRG1 antibody [EPNCIR111B] (ab133257) at 1/1000 dilution
Lane 1:
K562 cell lysate at 10 µg
Lane 2:
HeLa cell lysate at 10 µg
Lane 3:
Molt 4 cell lysate at 10 µg
Lane 4:
PC12 cell lysate at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP conjugated antibody. at 1/2000 dilution
Predicted band size: 185 kDa
false
- WB
Lab
Western blot - Anti-BRG1 antibody [EPNCIR111B] (AB133257)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : BRG1 knockout HAP1 cell lysate (20 μg)
Lane 3 : HeLa cell lysate (20 μg)
Lane 4 : K562 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab133257 observed at 240 kDa. Red - loading control, ab18058, observed at 124 kDa.
ab133257 was shown to recognize BRG1 when BRG1 knockout samples were used, along with additional cross-reactive bands. Wild-type and BRG1 knockout samples were subjected to SDS-PAGE. ab133257 and ab18058 (loading control to vinculin) were diluted at 1/1000 and 1/10000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776 secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-BRG1 antibody [EPNCIR111B] (ab133257)
Predicted band size: 185 kDa
false
Related conjugates and formulations (1)
-
Anti-BRG1 antibody [EPNCIR111B] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Collaborations
This antibody was developed as part of a collaboration between Epitomics, the National Cancer Institute's Center for Cancer Research and the lab of Gordon Hager.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Cell proliferation 58:e13794 PubMed39710429
2024
Applications
Unspecified application
Species
Unspecified reactive species
European journal of clinical investigation 52:e13769 PubMed35316536
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com